Impact of obesity on female fertility and fertility treatment

Women's Health

Volumn 4, Issue 2, 2008, Pages 183-194

  Zain, Murizah M ^a,b   Norman, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Alor Setar Hospital Malaysia   (Malaysia)

Author keywords

Fertility; Fertility treatment; Obesity; Overweight

Indexed keywords

ANTIOBESITY AGENT; CLOMIFENE; FENFLURAMINE; FOLIC ACID; FOLLITROPIN; GONADOTROPIN; INSULIN; MAZINDOL; METFORMIN; PHENYLPROPANOLAMINE; PLACEBO; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THYROID HORMONE;

ABDOMINAL OBESITY; ANOVULATION; BARIATRIC SURGERY; BEHAVIOR MODIFICATION; BODY MASS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MECHANISM; DRUG MEGADOSE; EXERCISE; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LONG TERM CARE; MENORRHAGIA; MENSTRUAL IRREGULARITY; MORBID OBESITY; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; NEWBORN DISEASE; OBESITY; OMPHALOCELE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY RATE; PREVALENCE; REVIEW; RISK FACTOR; RISK REDUCTION; ROUX Y ANASTOMOSIS; SPINA BIFIDA; SPONTANEOUS ABORTION; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

BODY MASS INDEX; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; WEIGHT LOSS;

EID: 41949105511     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.2.183     Document Type: Review

References (78)

1. World Health Organization: Obesity preventing and managing the global epidemic. Report of a WHO consultation on Obesity WHO/NUT/NCD 98.1. World Health Organization, Geneva, Switzerland (1997).
2. Kouris-Blazos A, Wahlqvist ML: Health economics of weight management: evidence and cost. Asia Pac. J. Clin. Nutr. 16(1), 329-338 (2007).
3. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29, 181-191 (1934).
4. Kirschner MA: Obesity, androgens, oestrogens, and cancer risk. Cancer Res. 42, 3281-3285 (1982).
5. Bjorge T, Engeland A, Tretli S et al.: Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int. J. Cancer. 120(2), 378-383 (2007).
6. Reeves GK, Pirie K, Beral V et al.: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630), 1134 (2007).
7. Wolfe H: High prepregnancy body mass index- a maternal-fetal risk factor. N. Engl. J. Med. 338, 191-192 (1998).
8. Moyad MA: Current methods used for defining, measuring, and treating obesity. Semin. Urol. Oncol. 19(4), 247-256 (2001).
9. Siedell JC: The impact of obesity on health status: some implications for health care costs. Int. J. Obes. Relat. Metab. Disord. 19(6), S13-S16 (1995).
10. Hartz AJ, Rupley DC, Rimm AA: The association of girth measurements with disease in 32, 856 women. Am. J. Epidemiol. 119, 71-80 (1984).
11. Zaadstra BM, Seidell JC, Van Noord PA et al.: Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. Br. Med. J. 306, 484-487 (1993).
12. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697-738 (2000).
13. Ehrmann DA: Polycyctic ovary syndrome. N. Engl. J. Med. 352, 1223-1236 (2005).
14. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycyctic ovary syndrome. Hum. Reprod. 19, 41-47 (2004).
15. Pasquali R: Obesity, fat distribution and infertility. Maturitas 54, 363-371 (2006).
16. Balen AH, Conway GS, Kaltsas G et al.: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 10, 2107-2111 (1995).
17. Norman RJ, Masters SC, Hague W et al.: Metabolic approaches to the subclassification of polycyctic ovary syndrome. Fertil. Steril. 63, 329-335 1995.
18. Pasquali R, Gambineri A, Pagato U: The impact of obesity on reproduction in women with polycystic ovary syndrome. Br. J. Obstet. Gynaecol. 113, 1148-1159 (2006).
19. Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA: The association of obesity with infertility and related menstrual abnormalities in women. Int. J. Obes. 3, 57-73 (1979).
20. Lake JK, Power C, Cole TJ: Women's reproductive health: the role of body mass index in early and adult life. Int. J. Obes. Relat. Metab. Disord. 21, 432-438 (1997).
21. Norman RJ, Clark AM: Obesity and reproductive disorders: a review. Reprod. Fertil. Dev. 10, 55-63 (1998).
22. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A: Obesity and reproductive disorders in women. Human Reprod. Update 9(4), 359-237 (2003).
23. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ: Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil. Steril. 77, 209-215 (2002).
24. Budak E, Sanchez MF, Bellver J, Cervero A, Simon C, Pellicer A: Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil. Steril. 85, 1563-1581 (2006)
25. Gosman GG, Katcher HI, Legro RS: Obesity and the role of gut and adipose hormones in female reproduction. Hum. Reprod. Update 12(5), 585-601 (2006).
26. Moschos S, Chan JL, Mantzoros CS: Leptin and reproduction: a review. Fertil. Steril. 77, 433-444 (2002).
27. Gonzalez RR, Simon C, Caballero-Campo P, Norman R, Chardonnens D, Devoto L et al.: Leptin and reproduction. Hum. Reprod. Update 6, 290-300 (2000).
28. Rich-Edwards JW, Goldman MB, Willett WC et al.: Adolescent body mass index and infertility caused by ovulatory disorder. Am. J. Obstet. Gynecol. 171, 171-177 (1994).
29. Rich-Edwards JW, Spiegelman D, Garland M et al.: Physical activity, body mass index and ovulatory disorder infertility. Epidemiology 13, 184-190 (2002).
30. Gesink Law DC, Maclehose RF, Longnecker MP: Obesity and time to pregnancy. Hum. Reprod. 22(2), 414-420 (2007).
31. Dickey RP, Taylor SN, Curole DN et al.: Relationship of clomiphene dose and patient weight to successful treatment. Hum. Reprod. 12, 449-453 (1997).
32. Loh S, Wang JX, Matthews CD: The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients. Hum. Reprod. 17, 1207-1211 (2002).
33. Dodson WC, Kunselman AR, Legro RS: Association of obesity with treatment outcomes in ovulatory infertile women undergoing superovulation and intrauterine insemination. Fertil. Steril. 86, 642-646 (2006).
34. Balen A, Platteau F, Anderson A et al.: The influence of body weight on response to ovulation induction with gonadotrophins in 335 wornen with World Health Organization group II anovulatory infertility. Br. J. Obstet. Gynaecol. 113, 1195-1202 (2006).
35. Fedorcsák P, Date PO, Storeng R et al.: Impact of overweight and underweight on assisted reproduction treatment. Hum. Reprod. 19(11), 2523-2528 (2004).
36. Wang JX, Davies M, Norman RJ: Body mass index and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 321, 1320-1321 (2000).
37. Nicholas JE, Crane MM, Higdon HL, Miller PB, Boone WR: Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil. Steril. 79, 645-647 (2003).
38. Lashen H, Ledger W, Bernal AL, Barlow D: Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Human Reprod. 14, 712-715 (1999).
39. Lashen H, Fear K, Sturdee DW: Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case control study. Hum. Reprod. 19(7), 1644-1646 (2004).
40. Fedorcsák F, Dale PO, Storeng R et al.: Obesity is associated with early pregnancy loss after IVF or ICSI. Acta Obstet. Gynecol. Scand. 79, 43-48 (2000).
41. Wang JX, Davies M, Norman RJ: Obesity increases the risk of spontaneous abortion during infertility treatment. Obes. Res. 10(6), 551-554 (2002).
42. Styne-Gross A, Elkind-Hirsch K, Scott R: Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil. Steril. 83, 1629-1634 (2005).
43. Wattanakumtornkul S, Damario MA, Stevens Hall SA, Thornhill AR, Tummon IS: Body mass index and uterine receptivity in the oocyte donation model. Fertil. Steril. 80, 336-340 (2003).
44. Bellver J, Rossal LP, Bosch E, Zuniga A, Corona JT, Melendez F: Obesity and the risk of spontaneous abortion after oocyte donation. Fertil. Steril. 79, 1136-1140 (2003).
45. Bellver J, Melo MA, Bosch E, Serra V, Remohi J, Pellicer A: Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil. Steril.. 88, 446-451 (2007).
46. Farquhar CM, Gillett WR: Prioritising for fertility treatments-should a high BMI exclude treatment. Br. J. Obstet Gynaecol. 113, 1107-1109 (2006).
47. Gillet W. Putt T. Farquhar CM: Prioritising for fertility treatments - the effect of excluding women with a high body mass index. Br. J. Obstet. Gynaecol. 113, 1218-1221 (2006).
48. Raatikainen K, Heiskanen N, Heinonen S: Transition from overweight to obesity worsens pregnancy outcome in a BMI-dependant manner. Obesity 14, 165-171 (2006).
49. Callaway LK, Prins JB, Chang AM, McIntyre HD: The prevalence and impact of overweight and obesity in an Australian Obstetric population. Med. J. Aust. 184, 56-59 (2006).
50. Watkins ML, Rasmussen SA, Henein MA, Botto LD, Moore CA: Maternal obesity and risk for birth defects. Pediatrics 111 (5), 1152-1158 (2003).
51. Waller DK, Shaw GM, Rasmussen SA et al.: Prepregnancy obesity as a risk factor for structural With defects. Arch. Pediatr. Adolesc. Med. 161(8), 745-750 (2007).
52. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ: Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 7(5), 507-512 (1996).
53. Werler MM, Louik C, Shapiro S, Mitchell AA: Prepregnant weight in relation to risk of neural tube defects. JAMA 275, 1089-1092 (1996).
54. Tabor A, Zdravkovic M, Perslev A, Møller LK, Pedersen BL: Screening tor congenital malformations by ultrasonography in the general population of pregnant women: factors affecting the efficacy. Acta Obstet. Gynecol. Scand. 83, 1092-1098 (2003).
55. Huber-Buchholz MM, Carey DG, Norman RJ: Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J. Clin. Endocrinol Metab. 84, 1470-1474 (1999).
56. National Institutes of Health: Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: evidence report. Obes. Res. 6(S2), S51S-S209 (1998).
57. Bates GW, Whitworth NS: Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil, Steril. 38, 406-409 (1982).
58. Pettigrew R, Hamilton-Fairley D: Obesity and female reproductive function. Br. Med. Bull. 53, 341-358 (1997).
59. Moran LJ, Norman RJ: The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr. Clin. Care. 5(6), 290-297 (2002).
60. Garrow JS, Summerbell CD: Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects, Eur. J. Clin. Nutr. 49, 1-10 (1995).
61. Skender ML, Goodrick GK, Del Junco DJ et al.: Comparison of 2 year weight loss trends in behavioural treatments of obesity: diet, exercise and combination interventions. J. Am. Diet Assoc. 96, 342-346 (1996).
62. Satcher D: Women and smoking: a report of the Surgeon General, Atlanta, GA: Centers for Disease Control and Prevention (2001).
63. Grodstein F, Goldman MB, Cramer DW: Infertility in women and moderate alcohol use. Am. J. Public Health. 84, 1429-1432 (1994)
64. Hu FB, Manson JE, Stampfer MJ et al.: Diet, lifestyle and the risk of type 2 diabetes mellitus in women. N. Engl, J. Med. 344(18), 1343-1350 (2001).
65. Clark AM, Ledger W, Galletly C et al.: Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod. 10(10), 2705-2712 (1995).
66. Clark AM, Thornley B, Tomlinson L et al.: Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod. 13(6) 1502-1505 (1998).
67. Moran LJ, Noakes M, Clifton PM et al.: Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88(2), 812-819 (2003).
68. Padwal R Li SK, Lau DCW: Long term pharmacotherapy for obesity and overweight. Cochrane Database of Systematic Review 2003. 335(7631), 1194-1199 (2007).
69. Tang T, Glanville J. Hayden CJ et al.: Combined lifestyle modification and metformin in obese patients with polycyctic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum. Reprod. 21(1), 80-89 (2006).
70. Lord JM, Flight IHK, Norman RJ: Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327, 951-953 (2003).
71. Moll E, Bossuyt P, Korevaar J et al.: Effects of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycyctic ovary syndrome: randomized double blind clinical trial. BMJ 332, 1485-1492 (2006).
72. Legro, RS, Barnhart HX, Schlaff WD et al.: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 356, 551-566 (2007).
73. Salameh J: Bariatric surgery: past and present. Am. J. Med. Sci. 331, 194-199 (2006).
74. Korenkov M: Bariatric surgery. Contrib. Nephrol. 151, 243-253 (2006).
75. Kendrick ML, Dakin GF: Surgical approaches to obesity. Mayo Clin. Proc. 81(10S), S18-S24 (2006).
76. Escobar-Morreale H, Jose I, Botella C et al.: The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J. Clin. Endocrinol. Metab. 90(12), 6364-6369 (2005).
77. Eid GM, Cottam DR, Velcu LM et al.: Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 1(2), 77-80 (2005).
78. Teitelman M, Grotegut CA, Williams NN, Lewis JD: The impact of bariatric surgery on menstrual pattern. Obes. Surg. 16(11), 1457-1463 (2006).